Current browse context:
q-bio.NC
Change to browse by:
References & Citations
Quantitative Biology > Neurons and Cognition
Title: Blood-based metabolic signatures in Alzheimer's disease
(Submitted on 21 Sep 2017)
Abstract: Introduction: Identification of blood-based metabolic changes might provide early and easy-to-obtain biomarkers.
Methods: We included 127 AD patients and 121 controls with CSF-biomarker-confirmed diagnosis (cut-off tau/A$\beta_{42}$: 0.52). Mass spectrometry platforms determined the concentrations of 53 amine, 22 organic acid, 120 lipid, and 40 oxidative stress compounds. Multiple signatures were assessed: differential expression (nested linear models), classification (logistic regression), and regulatory (network extraction).
Results: Twenty-six metabolites were differentially expressed. Metabolites improved the classification performance of clinical variables from 74% to 79%. Network models identified 5 hubs of metabolic dysregulation: Tyrosine, glycylglycine, glutamine, lysophosphatic acid C18:2 and platelet activating factor C16:0. The metabolite network for APOE $\epsilon$4 negative AD patients was less cohesive compared to the network for APOE $\epsilon$4 positive AD patients.
Discussion: Multiple signatures point to various promising peripheral markers for further validation. The network differences in AD patients according to APOE genotype may reflect different pathways to AD.
Submission history
From: Carel F.W. Peeters [view email][v1] Thu, 21 Sep 2017 12:47:43 GMT (15233kb,D)
Link back to: arXiv, form interface, contact.